US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist
  • 1.6400
  • -0.0200-1.20%
Close Aug 30 16:00 ET
  • 1.6400
  • 0.00000.00%
Post 20:01 ET
43.97MMarket Cap-377P/E (TTM)

Syros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-33.23%9.94M
151.19%386K
-3.32%3.76M
-54.86%2.83M
-45.97%2.95M
-36.65%14.88M
-109.66%-754K
-31.70%3.89M
Operating revenue
--0
--0
-33.23%9.94M
151.19%386K
-3.32%3.76M
-54.86%2.83M
-45.97%2.95M
-36.65%14.88M
-109.66%-754K
-31.70%3.89M
Cost of revenue
Gross profit
Operating expense
-25.57%27.42M
-14.50%30.92M
-3.40%136.44M
-22.28%27.39M
6.53%36.04M
-8.02%36.83M
12.60%36.17M
14.92%141.24M
6.07%35.24M
3.76%33.84M
Selling and administrative expenses
-24.39%5.46M
-15.38%6.27M
-3.47%28.28M
-19.66%5.89M
-3.86%7.76M
4.03%7.23M
6.56%7.41M
27.19%29.3M
13.98%7.33M
51.07%8.08M
-General and administrative expense
-24.39%5.46M
-15.38%6.27M
-3.47%28.28M
-19.66%5.89M
-3.86%7.76M
4.03%7.23M
6.56%7.41M
27.19%29.3M
13.98%7.33M
51.07%8.08M
Research and development costs
-25.85%21.95M
-14.28%24.66M
-3.39%108.15M
-22.97%21.5M
9.79%28.28M
-10.55%29.61M
14.26%28.76M
12.09%111.94M
4.18%27.91M
-5.51%25.76M
Operating profit
19.36%-27.42M
6.90%-30.92M
-0.11%-126.5M
24.98%-27.01M
-7.81%-32.28M
-0.68%-34M
-24.61%-33.21M
-27.10%-126.36M
-41.59%-36M
-11.27%-29.94M
Net non-operating interest income expense
-135.06%-297K
-57.17%239K
184.37%1.69M
-109.85%-46K
150.08%330K
197.47%847K
159.30%558K
47.59%-2M
148.90%467K
30.78%-659K
Non-operating interest income
-48.94%1.09M
-12.90%1.55M
219.70%6.82M
-19.46%1.28M
316.58%1.63M
1,797.32%2.13M
4,971.43%1.78M
2,350.57%2.13M
5,038.71%1.59M
1,125.00%392K
Non-operating interest expense
8.14%1.38M
7.40%1.31M
24.02%5.13M
18.03%1.33M
23.98%1.3M
30.28%1.28M
24.69%1.22M
5.81%4.13M
14.20%1.13M
6.81%1.05M
Other net income (expense)
241.26%4.39M
204.28%26.97M
-217.96%-39.76M
-221.38%-37.33M
-2,440.29%-8.19M
-2,077.71%-3.11M
262.13%8.87M
102.08%33.71M
1,099.06%30.76M
-80.94%350K
Gain on sale of security
241.26%4.39M
204.28%26.97M
-186.24%-37.28M
-220.95%-37.2M
-159.20%-5.84M
-2,077.71%-3.11M
262.13%8.87M
159.09%43.22M
1,099.06%30.76M
437.04%9.86M
Special income (charges)
----
----
73.83%-2.49M
---135K
75.25%-2.35M
----
----
---9.51M
--0
---9.51M
-Less：Restructuring and merger&acquisition
----
----
-73.83%2.49M
--135K
-75.25%2.35M
----
----
--9.51M
--0
--9.51M
Income before tax
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
-16.24%-30.25M
Income tax
Net income
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
-16.24%-30.25M
Net income continuous Operations
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
-16.24%-30.25M
Minority interest income
Net income attributable to the parent company
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
-16.24%-30.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
-16.24%-30.25M
Basic earnings per share
54.62%-0.59
88.24%-0.1
22.43%-5.81
-842.28%-2.22
55.45%-1.43
75.93%-1.3
78.70%-0.85
45.88%-7.49
93.77%-0.2356
22.46%-3.21
Diluted earnings per share
54.62%-0.59
88.24%-0.1
22.43%-5.81
-842.28%-2.22
55.45%-1.43
75.93%-1.3
78.70%-0.85
45.88%-7.49
93.77%-0.2356
22.46%-3.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-33.23%9.94M151.19%386K-3.32%3.76M-54.86%2.83M-45.97%2.95M-36.65%14.88M-109.66%-754K-31.70%3.89M
Operating revenue --0--0-33.23%9.94M151.19%386K-3.32%3.76M-54.86%2.83M-45.97%2.95M-36.65%14.88M-109.66%-754K-31.70%3.89M
Cost of revenue
Gross profit
Operating expense -25.57%27.42M-14.50%30.92M-3.40%136.44M-22.28%27.39M6.53%36.04M-8.02%36.83M12.60%36.17M14.92%141.24M6.07%35.24M3.76%33.84M
Selling and administrative expenses -24.39%5.46M-15.38%6.27M-3.47%28.28M-19.66%5.89M-3.86%7.76M4.03%7.23M6.56%7.41M27.19%29.3M13.98%7.33M51.07%8.08M
-General and administrative expense -24.39%5.46M-15.38%6.27M-3.47%28.28M-19.66%5.89M-3.86%7.76M4.03%7.23M6.56%7.41M27.19%29.3M13.98%7.33M51.07%8.08M
Research and development costs -25.85%21.95M-14.28%24.66M-3.39%108.15M-22.97%21.5M9.79%28.28M-10.55%29.61M14.26%28.76M12.09%111.94M4.18%27.91M-5.51%25.76M
Operating profit 19.36%-27.42M6.90%-30.92M-0.11%-126.5M24.98%-27.01M-7.81%-32.28M-0.68%-34M-24.61%-33.21M-27.10%-126.36M-41.59%-36M-11.27%-29.94M
Net non-operating interest income expense -135.06%-297K-57.17%239K184.37%1.69M-109.85%-46K150.08%330K197.47%847K159.30%558K47.59%-2M148.90%467K30.78%-659K
Non-operating interest income -48.94%1.09M-12.90%1.55M219.70%6.82M-19.46%1.28M316.58%1.63M1,797.32%2.13M4,971.43%1.78M2,350.57%2.13M5,038.71%1.59M1,125.00%392K
Non-operating interest expense 8.14%1.38M7.40%1.31M24.02%5.13M18.03%1.33M23.98%1.3M30.28%1.28M24.69%1.22M5.81%4.13M14.20%1.13M6.81%1.05M
Other net income (expense) 241.26%4.39M204.28%26.97M-217.96%-39.76M-221.38%-37.33M-2,440.29%-8.19M-2,077.71%-3.11M262.13%8.87M102.08%33.71M1,099.06%30.76M-80.94%350K
Gain on sale of security 241.26%4.39M204.28%26.97M-186.24%-37.28M-220.95%-37.2M-159.20%-5.84M-2,077.71%-3.11M262.13%8.87M159.09%43.22M1,099.06%30.76M437.04%9.86M
Special income (charges) --------73.83%-2.49M---135K75.25%-2.35M-----------9.51M--0---9.51M
-Less：Restructuring and merger&acquisition ---------73.83%2.49M--135K-75.25%2.35M----------9.51M--0--9.51M
Income before tax 35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M-16.24%-30.25M
Income tax
Net income 35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M-16.24%-30.25M
Net income continuous Operations 35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M-16.24%-30.25M
Minority interest income
Net income attributable to the parent company 35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M-16.24%-30.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M-16.24%-30.25M
Basic earnings per share 54.62%-0.5988.24%-0.122.43%-5.81-842.28%-2.2255.45%-1.4375.93%-1.378.70%-0.8545.88%-7.4993.77%-0.235622.46%-3.21
Diluted earnings per share 54.62%-0.5988.24%-0.122.43%-5.81-842.28%-2.2255.45%-1.4375.93%-1.378.70%-0.8545.88%-7.4993.77%-0.235622.46%-3.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg